Investigation of forestry resources and other remote sensing data. 1: LANDSAT. 2: Remote sensing of volcanic emissions

Computer classification of LANDSAT data was used for forest type mapping in New England. The ability to classify areas of hardwood, softwood, and mixed tree types was assessed along with determining clearcut regions and gypsy moth defoliation. Applications of the information to forest management and locating potential deer yards were investigated. The principal activities concerned with remote sensing of volcanic emissions centered around the development of remote sensors for SO2 and HCl gas, and their use at appropriate volcanic sites. Two major areas were investigated (Masaya, Nicaragua, and St. Helens, Washington) along with several minor ones

An investigation of vegetation and other Earth resource/feature parameters using LANDSAT and other remote sensing data. 1: LANDSAT. 2: Remote sensing of volcanic emissions

There are no author-identified significant results in this report

An investigation of vegetation and other Earth resource/feature parameters using LANDSAT and other remote sensing data. 1: LANDSAT. 2: Remote sensing of volcanic emissions

A fanning technique based on a simplistic physical model provided a classification algorithm for mixture landscapes. Results of applications to LANDSAT inventory of 1.5 million acres of forest land in Northern Maine are presented. Signatures for potential deer year habitat in New Hampshire were developed. Volcanic activity was monitored in Nicaragua, El Salvador, and Guatemala along with the Mt. St. Helens eruption. Emphasis in the monitoring was placed on the remote sensing of SO2 concentrations in the plumes of the volcanoes

An investigation of vegetation and other earth resource/feature parameters using LANDSAT and other remote sensing data. A: LANDSAT. B: Remote sensing of volcanic emissions

There are no author-identified significant results in this report

An investigation of vegetation and other earth resource/feature parameters using LANDSAT and other remote sensing data. A: LANDSAT. B: Remote sensing of volcanic emissions

There are no author-identified significant results in this report

Lithologic mapping of mafic intrusions in East Greenland using Landsat Thematic Mapper data

The East Greenland Tertiary Igneous Province contains a variety of intrusive and extrusive rock types. The Skaergaard complex is the most well known of the intrusive centers. Landsat thematic mapping (TM) was used in conjunction with field spectrometer data to map these mafic intrusions. These intrusions are of interest as possible precious metal ore deposits. They are spectrally distinct from the surrounding Precambrian gneisses. However, subpixel contamination by snow, oxide surface coatings, lichen cover and severe topography limit the discrimination of lithologic units within the gabbro. Imagery of the Skaergaard and surrounding vicinity, and image processing and enhancement techniques are presented. Student theses and other publications resulting from this work are also listed

Comparison of the Electronic Structures and Energetics of Ferroelectric LiNbO3 and LiTaO3

This paper explains the origin of the ferroelectric instability in LiNbO3 and LiTaO3 and compares the electronic structures and energetics of the two materials.Comment: 31 pages, 11 Postscript figure

Health Outcomes and Cost-effectiveness of Monoclonal SARS-CoV-2 Antibodies as Pre-exposure Prophylaxis

Importance: Pre-exposure prophylaxis with neutralizing SARS-CoV-2 monoclonal antibodies (mAbs PrEP) prevents infection and reduces hospitalizations and the duration thereof for COVID-19 and death among high-risk individuals. However, reduced effectiveness due to a changing SARS-CoV-2 viral landscape and high drug prices remain substantial implementation barriers. Objective: To assess the cost-effectiveness of mAbs PrEP as COVID-19 PrEP. Design, Setting, and Participants: For this economic evaluation, a decision analytic model was developed and parameterized with health care outcome and utilization data from individuals with high risk for COVID-19. The SARS-CoV-2 infection probability, mAbs PrEP effectiveness, and drug pricing were varied. All costs were collected from a third-party payer perspective. Data were analyzed from September 2021 to December 2022. Main Outcomes and Measures: Health care outcomes including new SARS-CoV-2 infections, hospitalization, and deaths. The cost per death averted and cost-effectiveness ratios using a threshold for prevention interventions of $22000 or less per quality-adjusted life year (QALY) gained. Results: The clinical cohort consisted of 636 individuals with COVID-19 (mean [SD] age 63 [18] years; 341 [54$275 and 75% or higher effectiveness. With a 100% effectiveness mAbs PrEP can reduce ward admissions by 70%, ICU admissions by 97%, and deaths by 92%. Drug prices, however, need to reduce to $550 for cost-effectiveness ratios less than$22000 per QALY gained per death averted and to $2200 for ratios between$22000 and $88000. Conclusions and Relevance: In this study, use of mAbs PrEP for preventing SARS-CoV-2 infections was cost-saving at the beginning of an epidemic wave (high infection probability) with 75$275. These results are timely and relevant for decision-makers involved in mAbs PrEP implementation. When newer mAbs PrEP combinations become available, guidance on implementation should be formulated ensuring a fast rollout. Nevertheless, advocacy for mAbs PrEP use and critical discussion on drug prices are necessary to ensuring cost-effectiveness for different epidemic settings.</p

Please mind the gap: students’ perspectives of the transition in academic skills between A-level and degree level geography

This paper explores first-year undergraduates’ perceptions of the transition from studying geography at pre-university level to studying for a degree. This move is the largest step students make in their education, and the debate about it in the UK has been reignited due to the government’s planned changes to A-level geography. However, missing from most of this debate is an appreciation of the way in which geography students themselves perceive their transition to university. This paper begins to rectify this absence. Using student insights, we show that their main concern is acquiring the higher level skills required for university learning

Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillation is associated with an increased risk of stroke by a factor of 2.5; however, treatment with oral anticoagulation is of uncertain benefit.We conducted a trial involving patients with subclinical atrial fibrillation lasting 6 minutes to 24 hours. Patients were randomly assigned in a double-blind, double-dummy design to receive apixaban at a dose of 5 mg twice daily (2.5 mg twice daily when indicated) or aspirin at a dose of 81 mg daily. The trial medication was discontinued and anticoagulation started if subclinical atrial fibrillation lasting more than 24 hours or clinical atrial fibrillation developed. The primary efficacy outcome, stroke or systemic embolism, was assessed in the intention-to-treat population (all the patients who had undergone randomization); the primary safety outcome, major bleeding, was assessed in the on-treatment population (all the patients who had undergone randomization and received at least one dose of the assigned trial drug, with follow-up censored 5 days after permanent discontinuation of trial medication for any reason).We included 4012 patients with a mean (±SD) age of 76.8±7.6 years and a mean CHA2DS2-VASc score of 3.9±1.1 (scores range from 0 to 9, with higher scores indicating a higher risk of stroke); 36.1% of the patients were women. After a mean follow-up of 3.5±1.8 years, stroke or systemic embolism occurred in 55 patients in the apixaban group (0.78% per patient-year) and in 86 patients in the aspirin group (1.24% per patient-year) (hazard ratio, 0.63; 95% confidence interval [CI], 0.45 to 0.88; P = 0.007). In the on-treatment population, the rate of major bleeding was 1.71% per patient-year in the apixaban group and 0.94% per patient-year in the aspirin group (hazard ratio, 1.80; 95% CI, 1.26 to 2.57; P = 0.001). Fatal bleeding occurred in 5 patients in the apixaban group and 8 patients in the aspirin group.Among patients with subclinical atrial fibrillation, apixaban resulted in a lower risk of stroke or systemic embolism than aspirin but a higher risk of major bleeding. (Funded by the Canadian Institutes of Health Research and others; ARTESIA ClinicalTrials.gov number, NCT01938248.)